Publication | Closed Access

Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2

Medicinal ChemistryNovel Quinazoline DerivativesDual InhibitorsAnilide TailsDrug DiscoveryMedicineRational Drug DesignPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyBiomolecular Engineering